Form 4: Pfizer Director James Quincey Acquires Phantom Stock Units
Statement of Changes in Beneficial Ownership
Pfizer Inc. director James Quincey was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.
Summary
- Director James Quincey acquired 7,686.539 phantom stock units on April 23, 2026.
- The units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
- Each phantom unit represents one share of common stock, valued at $26.67 per unit.
- Following this transaction, the director holds a total of 85,004.077 phantom stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices rather than a strategic shift.
Positives
- Demonstrates alignment of director interests with long-term shareholder value through equity-linked compensation.
Negatives
- None identified.
Risks
- Value of phantom stock units is subject to the future market performance of Pfizer common stock.
Future Outlook
The phantom stock units are settled in cash or common stock at the director's election following their retirement from the Board of Directors.
Management Comments
- The units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of director compensation, common among large-cap pharmaceutical companies to ensure board members maintain a financial stake in the company's performance.
Comparison to Industry Standards
- The use of deferred compensation plans for non-employee directors is a standard governance practice among S&P 500 companies, including peers like Merck and Bristol Myers Squibb.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of phantom stock units under the Nonfunded Deferred Compensation and Unit Award Plan. | 04/23/2026 | Standard alignment of director compensation with company equity performance. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard board compensation structure.
Next Steps
- The director will hold these units until retirement from the Board of Directors.
Key Dates
| Date | Description |
|---|---|
| 04/23/2026 | Date of the phantom stock unit grant transaction. |
| 04/27/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Pfizer, PFE, Form 4, Director Compensation, Insider Transaction, Phantom Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.